| Acute Myeloid Leukemia with Maturation studied in …STUDIED_INderived75 of 75show fewer |
|---|
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822015early Phase 1 · completed Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369317Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Childhood Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02144675Phase 2 · completed Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307579Phase 3 · completed Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235572Phase 2 · completed Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045435Phase 2 · completed Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849276Phase 1 · terminated Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02019069Phase 2 · completed CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253447Phase 2 · completed AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666588Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049801Phase 1 · terminated MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01607645Phase 2 · terminated Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02944162Phase 1/Phase 2 · unknown CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076569completed Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Childhood Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146210completed Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Childhood Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029417Phase 2 · terminated Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01127009Phase 1 · completed Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634244Phase 2 · completed Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01521936Phase 2 · terminated Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00383474Phase 1 · completed Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602771Phase 2 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00742625Phase 1/Phase 2 · completed Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096122Phase 1/Phase 2 · completed Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305773Phase 2 · completed Vorinostat in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098423Phase 1 · completed Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301938Phase 1 · completed 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470197Phase 1 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159301Phase 1 · terminated Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003190Phase 3 · completed Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006363Phase 3 · completed Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101231Phase 1 · terminated Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103272Phase 1 · terminated 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027872Phase 2 · completed Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095797Phase 1 · completed XK469R in Treating Patients With Refractory Hematologic Cancer · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101296Phase 1 · completed Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096148Phase 2 · terminated Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042796Phase 1 · terminated Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Childhood Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002798Phase 3 · completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Childhood Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093418Phase 2 · completed S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098826Phase 1 · completed SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112853Phase 1 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131989Phase 1 · completed Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ALIAS · 75 trials mapped (2 active) | — | — | Adult Acute Myeloid Leukemia with Maturation | 1 | Observed | clinicaltrials | graph → |